These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 1636239

  • 1. Bacillus Calmette-Guérin immunotherapy. Techniques and results.
    Brosman SA.
    Urol Clin North Am; 1992 Aug; 19(3):557-64. PubMed ID: 1636239
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED.
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [Abstract] [Full Text] [Related]

  • 5. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB.
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [Abstract] [Full Text] [Related]

  • 6. A practical guide to the use of intravesical BCG for the management of stage Ta, T1, CIS, transitional cell cancer.
    Brosman SA, Lamm DL, van der Meijden AP, Debruyne FM.
    Prog Clin Biol Res; 1989 Nov; 310():311-23. PubMed ID: 2672019
    [Abstract] [Full Text] [Related]

  • 7. Managing superficial bladder cancer: an overview.
    Soloway MS.
    Urology; 1992 Dec; 40(6 Suppl):5-10. PubMed ID: 1466119
    [Abstract] [Full Text] [Related]

  • 8. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M, Guerin F, Amsellem-Ouazana D, Saighi D, Debre B, Zerbib M.
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [Abstract] [Full Text] [Related]

  • 9. Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments.
    Jauhiainen K, Rintala E.
    Ann Chir Gynaecol Suppl; 1993 Jun; 206():31-8. PubMed ID: 8291866
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
    Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA, Sullivan J, Sarosdy MF.
    N Engl J Med; 1991 Oct 24; 325(17):1205-9. PubMed ID: 1922207
    [Abstract] [Full Text] [Related]

  • 12. Superficial bladder disease: case studies and therapeutic advances.
    Soloway MS, Droller MJ, Flanigan RC, Nseyo UO.
    Urology; 1992 Dec 24; 40(6 Suppl):11-22. PubMed ID: 1466118
    [No Abstract] [Full Text] [Related]

  • 13. Instillation therapy in superficial urinary bladder cancer. Finnbladder Group.
    Jauhiainen KE, Alfthan OS.
    Scand J Urol Nephrol Suppl; 1991 Dec 24; 138():179-85. PubMed ID: 1785001
    [Abstract] [Full Text] [Related]

  • 14. In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guérin therapy without previous transurethral resection of the prostate.
    Palou J, Xavier B, Laguna P, Montlleó M, Vicente J.
    Urology; 1996 Apr 24; 47(4):482-4. PubMed ID: 8638354
    [Abstract] [Full Text] [Related]

  • 15. Long-term immunobiological effects of intravesical bacillus Calmette-Guérin against bladder carcinoma recurrences.
    Böhle A, Busemann E, Gerdes J, Ulmer AJ, Flad HD, Jocham D.
    Dev Biol Stand; 1992 Apr 24; 77():199-209. PubMed ID: 1426663
    [Abstract] [Full Text] [Related]

  • 16. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study.
    Martinez-Pineiro JA, Jimenez León J, Martinez-Pineiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    Prog Clin Biol Res; 1989 Apr 24; 310():237-52. PubMed ID: 2505269
    [Abstract] [Full Text] [Related]

  • 17. Treatment of superficial carcinoma of the bladder.
    Paulson DF.
    Prog Clin Biol Res; 1984 Apr 24; 162B():193-209. PubMed ID: 6209720
    [No Abstract] [Full Text] [Related]

  • 18. Intravesical chemotherapy: how effective is it?
    Heney NM.
    Urology; 1988 Mar 24; 31(3 Suppl):17-9. PubMed ID: 3126591
    [Abstract] [Full Text] [Related]

  • 19. Intravesical bacillus Calmette-Guérin therapy for T1 superficial bladder cancer.
    Demkow T, Alter A, Wiechno P.
    Urol Int; 2008 Mar 24; 80(1):74-9. PubMed ID: 18204238
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.